PTMC | VO | PTMC / VO | |
Gain YTD | 3.903 | 3.669 | 106% |
Net Assets | 452M | 177B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 441.00 | 13.00 | 3,392% |
Yield | 1.75 | 1.50 | 117% |
Fund Existence | 10 years | 21 years | - |
PTMC | VO | |
---|---|---|
RSI ODDS (%) | 11 days ago52% | 11 days ago84% |
Stochastic ODDS (%) | 11 days ago63% | 11 days ago90% |
Momentum ODDS (%) | 11 days ago57% | 11 days ago80% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 11 days ago66% | 11 days ago85% |
TrendMonth ODDS (%) | 11 days ago56% | 11 days ago79% |
Advances ODDS (%) | 13 days ago70% | 13 days ago84% |
Declines ODDS (%) | 20 days ago65% | 17 days ago79% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 11 days ago67% | 11 days ago84% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DVOL | 35.11 | 0.16 | +0.45% |
FirstTrustDorseyWrightMomt&LwVolatil ETF | |||
XMMO | 129.69 | 0.58 | +0.45% |
Invesco S&P MidCap Momentum ETF | |||
TPSC | 40.22 | 0.16 | +0.39% |
Timothy Plan US Small Cap Core ETF | |||
LGOV | 20.81 | 0.04 | +0.19% |
First Trust Long Duration Opp ETF | |||
CNCR | 11.67 | -0.03 | -0.26% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, PTMC has been closely correlated with AVNT. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTMC jumps, then AVNT could also see price increases.
Ticker / NAME | Correlation To PTMC | 1D Price Change % | ||
---|---|---|---|---|
PTMC | 100% | +0.58% | ||
AVNT - PTMC | 78% Closely correlated | +2.19% | ||
JHG - PTMC | 76% Closely correlated | +1.83% | ||
NOVT - PTMC | 76% Closely correlated | +1.33% | ||
SSB - PTMC | 75% Closely correlated | +1.11% | ||
CADE - PTMC | 74% Closely correlated | +1.02% | ||
More |